|
|
pQuiet-2U6-neo (Cat. #: P3210, 20mg,) (1322 reads) 
This vector can silence the
expression of 2 genes simultaneously. Sequences from the target genes are
used to design short cDNAs that are ligated into the insertion sites at each
end of the promoter. The cDNAs are constructed by annealing compementary oligonucleotides
to one another. Each oligonucleotide is designed with a 4-base overhang
at its 5'-end. The overhangs complement vector sequences that remain after
digestion with a pair of restriction enzymes that is unique for each insertion
site. The neomycin resistance marker facilitates the creation of stable
cell lines.
|
Position
|
Feature
|
|
2-27
|
I-Ceu I site
|
|
30-404
|
Adenovirus nt 1-375 (L.ITR, enhancer, packaging signal)
|
|
534-539
|
Spe I site
|
|
547-552
|
Mlu I site
|
|
998-1003
|
Bgl II site
|
|
1016-1023
|
Not I site
|
|
1476-3001
|
Neomycin resistance
|
|
3904
|
Replication origin
|
|
5065-5476
|
Cos site
|
|
6743-5500
|
Tetracycline resistance (Tetr )
|
|
[ Back to ] |
|
|
|
|